Skip to content

Clinical trials

Thrombocythemia, Essential trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Spain Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20131
20181
20191
20211
20233
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed6
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Shire3
Merck Sharp & Dohme LLC2
AOP Orphan Pharmaceuticals AG1
AbbVie1
European Organisation for Research and Treatment of Cancer - EORTC1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential14
Primary Myelofibrosis7
Myeloproliferative Disorders6
Polycythemia Vera5
Leukemia, Myelomonocytic, Chronic2
Neoplasms2
Recurrence2
Thrombocytosis2
Blast Crisis1
Blood Coagulation Disorders1

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.